Global Plasma Fractionation Market Research Report 2021

SKU ID : QYR- 17783546

Publishing Date : 23-Mar-2021

No. of pages : 114

PRICE
2900
5800


  • Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
    Baxter, CSL, Grifols are the leaders of the industry, with 71% market share, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
    North America is the largest sales place, with a consumption value market share nearly 39%. Following North America, Europe is the second largest sales place with the revenue market share of 25%. China is an important market of Blood Product in Asia, accounting for 14% revenue market share of global market.

    The global Plasma Fractionation market was valued at US$ 26040 million in 2020 and is expected to reach US$ 41450 million by the end of 2027, growing at a CAGR of 6.8% during 2021-2027.
    This report focuses on Plasma Fractionation volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Plasma Fractionation market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

    Global Plasma Fractionation Market: Segment Analysis
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Albumin
    Immune Globulin
    Coagulation Factor
    Other

    Segment by Application
    Immunity
    Hematology
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Shire (Baxalta)
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports